Management of treatment-resistant nocturnal enuresis

Area of Science:

• Pediatrics
• Urology

Background:

• Nocturnal enuresis, defined as sleep-related urinary incontinence in children aged 5+, affects treatment approaches.
• Revised Japanese guidelines in 2016 prompted increased pediatrician engagement in managing nocturnal enuresis.
• Monosymptomatic nocturnal enuresis management begins with lifestyle guidance, including nighttime fluid restriction.

Purpose of the Study:

• To outline treatment strategies for children with nocturnal enuresis unresponsive to initial therapies.
• To emphasize the importance of reassessing treatment efficacy and patient factors when first-line treatments fail.

Main Methods:

• Initial management involves lifestyle guidance (e.g., fluid restriction).
• If lifestyle changes are insufficient, aggressive treatments like oral desmopressin or alarm therapy are considered.
• For non-responders, reconfirming desmopressin administration and assessing alarm therapy suitability are crucial.

Main Results:

• Some children do not achieve sufficient reduction in wet nights with oral desmopressin or alarm therapy.
• Factors influencing desmopressin efficacy require re-evaluation in non-responders.
• Patients unsuitable for alarm therapy may not increase dry nights.

Conclusions:

• Persistent nocturnal enuresis after initial aggressive treatments necessitates immediate consideration of alternative strategies.
• Maintaining patient motivation is key when standard treatments prove ineffective.
• Comprehensive assessment is vital for optimizing treatment outcomes in pediatric nocturnal enuresis.